enoxaparin
enoxaparin: 3 clinical trials tracked.
enoxaparin evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about enoxaparin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 2 study sponsors
Related indications
Clinical Trial Registry Records (3)
A Phase I, Randomized, Single-blind, Placebo-controlled Study to Further Characterize Andexanet Posology and Assess the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
Primary endpoint: Anti-Factor (F) Xa activity
A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX)
Primary endpoint: Incidence of the composite endpoint of asymptomatic or symptomatic Venous Thromboembolism (VTE) [including VTE-related death]
A Phase 2, Multicenter, Randomized, Open-Label, Active Control Study of REGN7508, a Factor XI Monoclonal Antibody, for Prevention of Venous Thromboembolism After Elective, Unilateral, Total Knee Arthroplasty (ROXI-VTE II)
Primary endpoint: Percentage of Participants With Confirmed, Adjudicated Venous Thromboembolism (VTE)